EligibleTrials

Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)

Recruiting · NCT04874038 · Interventional (participants receive a specific treatment) · Lead sponsor: University Health Network, Toronto

View the official record on ClinicalTrials.gov →
Breast Cancer

Interventions studied

Lidocaine 20mg/mlPlacebo

What this trial is about

Phase III, international multicentre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of an intraoperative intravenous lidocaine infusion on reducing the development of persistent pain 3-months after breast cancer surgery.

Who can take part

Age range
18 Years to 100 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

17 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.